Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04839198Completed
Randomised, open-label trial (2 arms), sponsored by UTHealth Houston. Primary endpoint: Number of patients who quit smoking as confirmed by absence of salivary cotinine. Started Feb 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04839198.